Canopy Growth Corporation Common Shares (CGC) Financial Statements
Historical financial data — 21 statements covering FY2020–FY2026
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of dist...
Canopy Growth Corporation Common Shares's revenue increased 5.8% year over year, from $269.0M to $284.6M.
Net income increased 56.0% over the same period, from $-598.1M to $-262.9M.
Over the 6-year period from FY2020 to FY2026, revenue declined by 29% in total.
Total debt decreased by 27.6% to $217.1M.
The debt-to-equity ratio stands at 0.31, indicating a moderate leverage profile.
Operating cash flow grew 61.5% to $-63.8M.
Canopy Growth Corporation Common Shares maintains a negative net profit margin of -92.4%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2023 | $228.0M+107.0% | $-2.30B | $2.4M | $-2.01B | $-273.9M | $3.40B | $1.03B | $1.63B |
| Q3 FY2023 | $329.2M+44.4% | $-2.57B | $-12.0K | $-2.17B | $-417.8M | $3.02B | $750.1M | $1.43B |
| Q1 FY2024 | $66.2M-79.9% | $-127.1M | $23.0M | $-29.1M | $-51.8M | $1.29B | $558.5M | $532.9M |
| Q2 FY2025 | $129.2M+95.1% | $-255.4M | $44.9M | $-75.1M | $-105.6M | $1.23B | $415.9M | $509.7M |
| Q3 FY2025 | $204.0M+57.9% | $-377.3M | $69.0M | $-98.9M | $-132.6M | $1.16B | $438.4M | $591.5M |
| Q1 FY2026 | $72.1M-64.6% | $-41.5M | $18.0M | $-22.6M | $-10.3M | $904.7M | $289.0M | $489.0M |
| Q2 FY2026 | $138.8M+92.4% | $-43.2M | $39.9M | $-39.5M | $-28.3M | $1.07B | $226.3M | $736.0M |
| Q3 FY2026 | $213.4M+53.7% | $-105.8M | $61.4M | $-65.9M | $-45.6M | $1.11B | $225.0M | $758.2M |